146 related articles for article (PubMed ID: 37493099)
21. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
22. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
Taylor J; McCluggage WG
Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
[TBL] [Abstract][Full Text] [Related]
23. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.
Murray SK; Clement PB; Young RH
Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772
[TBL] [Abstract][Full Text] [Related]
24. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
25. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.
Kurman RJ; Kaminski PF; Norris HJ
Cancer; 1985 Jul; 56(2):403-12. PubMed ID: 4005805
[TBL] [Abstract][Full Text] [Related]
26. [Endometrial atypical complex hyperplasia with extensive squamous metaplasia: two cases].
Hannachi Sassi S; Dhouib R; Abbes I; Braham E; Mrad K; Driss M; Ben Hamida N; Ben Romdhane K
Ann Pathol; 2008 Jun; 28(3):233-6. PubMed ID: 18706369
[TBL] [Abstract][Full Text] [Related]
27. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN
Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573
[TBL] [Abstract][Full Text] [Related]
28. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
29. Simple and complex hyperplastic papillary proliferations of the endometrium: a clinicopathologic study of nine cases of apparently localized papillary lesions with fibrovascular stromal cores and epithelial metaplasia.
Lehman MB; Hart WR
Am J Surg Pathol; 2001 Nov; 25(11):1347-54. PubMed ID: 11684950
[TBL] [Abstract][Full Text] [Related]
30. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
Xiong Y; Xiong YY; Zhou YF
Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
[TBL] [Abstract][Full Text] [Related]
31. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
32. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
33. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
34. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
35. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
Lax S
Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
[TBL] [Abstract][Full Text] [Related]
36. Endometrial hyperplasia.
Mills AM; Longacre TA
Semin Diagn Pathol; 2010 Nov; 27(4):199-214. PubMed ID: 21309256
[TBL] [Abstract][Full Text] [Related]
37. Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion.
Longacre TA; Chung MH; Jensen DN; Hendrickson MR
Am J Surg Pathol; 1995 Apr; 19(4):371-406. PubMed ID: 7694941
[TBL] [Abstract][Full Text] [Related]
38. Utility of p63 and PTEN staining in distinguishing cervical microglandular hyperplasia from endometrial endometrioid carcinoma with microglandular/mucinous features.
Aoun BA; Skala SL
Histopathology; 2022 Jun; 80(7):1102-1111. PubMed ID: 35347751
[TBL] [Abstract][Full Text] [Related]
39. Endometrial Stromal Expression of ER, PR, and B-Catenin Toward Differentiating Hyperplasia Diagnoses.
Chatzipantelis P; Koukourakis M; Balaska K; Giatromanolaki A
Int J Surg Pathol; 2022 Aug; 30(5):492-498. PubMed ID: 34866456
[No Abstract] [Full Text] [Related]
40. Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy.
Gunderson CC; Dutta S; Fader AN; Maniar KP; Nasseri-Nik N; Bristow RE; Diaz-Montes TP; Palermo R; Kurman RJ
Gynecol Oncol; 2014 Jan; 132(1):33-7. PubMed ID: 24316307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
